Biotech Firm Omega Therapeutics Hits Ch. 11 To Restructure
By Emlyn Cameron · February 10, 2025, 12:02 PM EST
Biotechnology company Omega Therapeutics hit Chapter 11 in Delaware on Monday, listing over $140 million of debt on its petition and having filed a form with the U.S. Securities and Exchange...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login